🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Paced Heart Rate Acceleration for Cardiac Conditioning

RecruitingNAAges 18 Years - 120 YearsAllDenice Hodgson-Zingman, MD
NCT06332391 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A clinical trial of exercise-similar heart rate acceleration delivered via cardiac pacing vs. sham intervention in subjects at rest will be performed. The study population comprises subjects with guideline-directed medically managed left ventricular dysfunction due to ischemic or non-ischemic cardiomyopathy and an existing implantable cardioverter defibrillator or biventricular implantable cardioverter defibrillator. The purpose of the study is to understand how the heart rate pattern of exercise contributes to the considerable cardiac conditioning effects of exercise and estimate whether the pacing approach may have translational clinical applicability. Fifty-two subjects will be randomized, single-blinded, to either the pacing intervention or a sham intervention which they will receive once daily, 3 days/week for 6 weeks. Baseline symptoms and clinical test results will be compared to

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female sex * Age 18 years or greater * Available transportation for study visits * Left ventricular ejection fraction \< or = 40% despite at least 3 months guideline-directed medial therapy * NYHA class II-III heart failure symptoms * Atrial-lead inclusive implantable cardioverter defibrillator or biventricular defibrillator in place \> 3 months * Intrinsic or biventricular paced QRS duration of \<= 120 milliseconds Exclusion Criteria: * Age \< 18 years * Inability to ambulate safely * Congenital or primary valve disease * Ongoing (not suppressed) atrial arrhythmias * Left ventricular thrombus * Severe peripheral arterial disease that limits mobility * Hospital admission for life-threatening condition (e.g. heart failure, stroke) in the past 3 months * Major surgery in the past 3 months or anticipated during the period of study * Ventricular pacing indication in the absence of biventricular pacing * Life expectancy \< 1 year * Hemodialysis * Hematocrit \< 30% * Severe chronic lung disease that limits activity or requires oxygen * Pregnancy * Implantable cardioverter defibrillator battery longevity \< 1 year * Vulnerable populations such as prisoners and institutionalized individuals
💊

What it tests

  • Exercise-similar cardiac pacing
  • Sham cardiac pacing
📍

Where

1 site
University of Iowa Hospitals and Clinics
Iowa City, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy